U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07070830) titled 'Simplified Onboarding in Adults With Type 2 Diabetes' on June 26.
Brief Summary: This is an outpatient study testing different starting doses of insulin in participants with type 2 diabetes. Participants will manage their diabetes using the Omnipod M System. The system is comprised of an Omnipod M Pod, an Omnipod M Controller, and will be used with a Dexcom G6 continuous glucose monitoring sensor (CGM).
There is a precursory evaluation before the main, randomized trial. Participation in the precursory evaluation could last up to 12 weeks and participation in the randomized trial could last up to 6 weeks. During both the evaluation ...